Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Endoscopic Pituitary Surgery
NCT04863339Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tranexamic acid, sponsored by University of North Carolina at Chapel Hill. Planned start Mar 2022; status: withdrawn.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04863339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04863339.